Project Veritas’ sting claiming Pfizer 'mutating' Covid virus goes viral; company responds
Pfizer junks claims made in the heavily edited and viral video by a US-based far-right activist group; says it has not conducted “evolution research" in Pfizer-BioNTech mRNA vaccine.
Sun Pharma launches generic version of Pfizer's blockbuster cancer drug
The price of the palbociclib treatment, which used to be at least ₹50,000 a month, will come down substantially.
Covid vaccines help Pfizer, BioNTech, Sinovac, Moderna topple powerhouses GSK, Merck, Sanofi
While Pfizer became the largest seller of vaccines in 2021, the second and third spots were taken by BioNTech and Sinovec.
Hetero to sell the world’s only generic Covid pill at ₹5,000 per course
The company is likely to launch its brand ‘Nirmacom’ in 2-3 weeks and sales will be restricted to hospitals and for govt purchases in the initial stage to prevent misuse.
Pfizer oral pill for Covid-19 gets US FDA approval
Company to increase production of Paxlovid from 80 million to 120 million courses of treatment in 2022; plans to launch worldwide with voluntary licenses to other manufacturers
55 Indian pharma cos capable of mRNA vaccines
Almost every major Indian pharmaceutical company, including Cipla, Dr Reddy’s, Sun Pharma and Biocon, are on the list of companies which can produce mRNA Covid-19 vaccines
Coming soon! Oral pills to treat Covid-19
Pfizer's Paxlovid shows 90% efficacy, while much hyped MSD's Molnupiravir is less effective.
Vaccine cos, scientists in war mode to tame Omicron coronavirus
The quartet of vaccine-makers from the western world are ascertaining the need to tweak their vaccines for the Omicron, whereas WHO states it is too early to comment on its virulence.
Sun, Dr Reddy’s in Pfizer Covid-19 drug windfall
US company gives voluntary licence to the Medicines Patent Pool for supply to 95 low and middle income countries.
Mix and match vaccines, says Kiran Mazumdar-Shaw
In an exclusive conversation with Fortune India, the executive chairperson of Biocon says India should immediately start mixing and matching existing vaccines to accelerate the vaccination drive.